Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

HIV-1 accessory protein Vpr interacts with REAF/RPRD2 to mitigate its antiviral activity.

Gibbons JM, Marno KM, Pike R, Lee WJ, Jones CE, Ogunkolade BW, Pardieu C, Bryan A, Fu RM, Warnes G, Rowley PA, Sloan RD, McKnight Á.

J Virol. 2019 Nov 27. pii: JVI.01591-19. doi: 10.1128/JVI.01591-19. [Epub ahead of print]

PMID:
31776272
2.

Identification of a subset of trace amine-associated receptors and ligands as potential modulators of insulin secretion.

Cripps MJ, Bagnati M, Jones TA, Ogunkolade BW, Sayers SR, Caton PW, Hanna K, Billacura MP, Fair K, Nelson C, Lowe R, Hitman GA, Berry MD, Turner MD.

Biochem Pharmacol. 2019 Nov 1;171:113685. doi: 10.1016/j.bcp.2019.113685. [Epub ahead of print]

PMID:
31678493
3.

Is famine exposure during developmental life in rural Bangladesh associated with a metabolic and epigenetic signature in young adulthood? A historical cohort study.

Finer S, Iqbal MS, Lowe R, Ogunkolade BW, Pervin S, Mathews C, Smart M, Alam DS, Hitman GA.

BMJ Open. 2016 Nov 23;6(11):e011768. doi: 10.1136/bmjopen-2016-011768.

4.

Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation.

Bagnati M, Ogunkolade BW, Marshall C, Tucci C, Hanna K, Jones TA, Bugliani M, Nedjai B, Caton PW, Kieswich J, Yaqoob MM, Ball GR, Marchetti P, Hitman GA, Turner MD.

Cell Death Dis. 2016 Aug 11;7(8):e2329. doi: 10.1038/cddis.2016.203.

5.

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses.

Marno KM, Ogunkolade BW, Pade C, Oliveira NM, O'Sullivan E, McKnight Á.

Retrovirology. 2014 Jan 10;11:3. doi: 10.1186/1742-4690-11-3.

6.

BORIS/CTCFL is an RNA-binding protein that associates with polysomes.

Ogunkolade BW, Jones TA, Aarum J, Szary J, Owen N, Ottaviani D, Mumin MA, Patel S, Pieri CA, Silver AR, Sheer D.

BMC Cell Biol. 2013 Nov 26;14:52. doi: 10.1186/1471-2121-14-52.

7.

CTCF binds to sites in the major histocompatibility complex that are rapidly reconfigured in response to interferon-gamma.

Ottaviani D, Lever E, Mao S, Christova R, Ogunkolade BW, Jones TA, Szary J, Aarum J, Mumin MA, Pieri CA, Krawetz SA, Sheer D.

Nucleic Acids Res. 2012 Jul;40(12):5262-70. doi: 10.1093/nar/gks158. Epub 2012 Feb 25.

8.

Widespread expression of BORIS/CTCFL in normal and cancer cells.

Jones TA, Ogunkolade BW, Szary J, Aarum J, Mumin MA, Patel S, Pieri CA, Sheer D.

PLoS One. 2011;6(7):e22399. doi: 10.1371/journal.pone.0022399. Epub 2011 Jul 19.

9.

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.

Forshew T, Tatevossian RG, Lawson AR, Ma J, Neale G, Ogunkolade BW, Jones TA, Aarum J, Dalton J, Bailey S, Chaplin T, Carter RL, Gajjar A, Broniscer A, Young BD, Ellison DW, Sheer D.

J Pathol. 2009 Jun;218(2):172-81. doi: 10.1002/path.2558.

PMID:
19373855
10.

Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians.

Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, Hitman GA.

Diabetes. 2002 Jul;51(7):2294-300.

11.

Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase mRNA in individuals with colorectal cancer.

Ogunkolade BW, Boucher BJ, Fairclough PD, Hitman GA, Dorudi S, Jenkins PJ, Bustin SA.

Lancet. 2002 May 25;359(9320):1831-2.

PMID:
12044381
12.

An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1q.

McDermott MF, Aganna E, Hitman GA, Ogunkolade BW, Booth DR, Hawkins PN.

Arthritis Rheum. 2000 Sep;43(9):2034-40. Erratum in: Arthritis Rheum. 2000 Oct;43(10):2379.

13.

Type 1 diabetes in the offspring does not increase the risk of parental type 2 diabetes in South Indians.

Ramachandran A, Snehalatha C, Tuomilehto-Wolf E, Vidgren G, Ogunkolade BW, Vijay V, Hitman GA.

Diabetes Metab Res Rev. 1999 Sep-Oct;15(5):328-31.

PMID:
10585618
14.

Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos CI, Mulley J, Quane KA, Molloy MG, Ranki A, Powell RJ, Hitman GA, O'Shea JJ, Kastner DL.

Cell. 1999 Apr 2;97(1):133-44.

15.

Linkage of familial Hibernian fever to chromosome 12p13.

McDermott MF, Ogunkolade BW, McDermott EM, Jones LC, Wan Y, Quane KA, McCarthy J, Phelan M, Molloy MG, Powell RJ, Amos CI, Hitman GA.

Am J Hum Genet. 1998 Jun;62(6):1446-51.

16.

Exclusion of the familial Mediterranean fever locus as a susceptibility region for autosomal dominant familial Hibernian fever.

McDermott MF, McDermott EM, Quane KA, Jones LC, Ogunkolade BW, Curtis D, Waldron-Lynch F, Phelan M, Hitman GA, Molloy MG, Powell RJ.

J Med Genet. 1998 May;35(5):432-4.

17.

Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.

Hitman GA, Mannan N, McDermott MF, Aganna E, Ogunkolade BW, Hales CN, Boucher BJ.

Diabetes. 1998 Apr;47(4):688-90. No abstract available.

PMID:
9568705
18.

Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians.

McDermott MF, Ramachandran A, Ogunkolade BW, Aganna E, Curtis D, Boucher BJ, Snehalatha C, Hitman GA.

Diabetologia. 1997 Aug;40(8):971-5.

PMID:
9267994
19.

High-resolution mapping of the genes Kcnb3 and Ly63 on distal mouse chromosome 4.

Coleman MP, Buckmaster EA, Ogunkolade BW, Tarlton A, Lyon MF, Brown MC, Perry VH.

Mamm Genome. 1996 Jul;7(7):552-3. No abstract available.

PMID:
8672149
20.

A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4.

Lyon MF, Ogunkolade BW, Brown MC, Atherton DJ, Perry VH.

Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9717-20.

21.

Isoenzyme variation within the genus Cryptosporidium.

Ogunkolade BW, Robinson HA, McDonald V, Webster K, Evans DA.

Parasitol Res. 1993;79(5):385-8.

PMID:
8415544
22.

Interactions between the human monocytic leukaemia THP-1 cell line and Old and New World species of Leishmania.

Ogunkolade BW, Colomb-Valet I, Monjour L, Rhodes-Feuillette A, Abita JP, Frommel D.

Acta Trop. 1990 Mar;47(3):171-6.

PMID:
1971494
23.

A new vaccination procedure against cutaneous leishmaniasis.

Vouldoukis I, Frommel D, Ogunkolade BW, Monjour L.

Ann Trop Med Parasitol. 1989 Dec;83(6):645-6. No abstract available.

PMID:
2619382
24.

Vaccination trial against canine visceral leishmaniasis. Phocean Veterinary Study Group on Visceral Leishmaniasis.

Dunan S, Frommel D, Monjour L, Ogunkolade BW, Cruz A, Quilici M.

Parasite Immunol. 1989 Jul;11(4):397-402.

PMID:
2780090
25.

[Large-scale production of amastigotes by a human monoblastoid cell line].

Ogunkolade BW, Lasneret J, Monjour L, Colomb-Valet I, Rhodes-Feuillette A, Abita JP, Roseto A, Vouldoukis I, Bittoun P, Frommel D.

Ann Parasitol Hum Comp. 1989;64(3):238-40. French.

PMID:
2764454
26.

Inoculation of BALB/c mice against Leishmania major infection with Leishmania-derived antigens isolated by gel filtration.

Ogunkolade BW, Monjour L, Vouldoukis I, Rhodes-Feuillette A, Frommel D.

J Chromatogr. 1988 May 25;440:459-65.

PMID:
3403672
27.

Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice.

Frommel D, Ogunkolade BW, Vouldoukis I, Monjour L.

Infect Immun. 1988 Apr;56(4):843-8.

28.

Immunization of dogs with a Leishmania infantum-derived vaccine.

Ogunkolade BW, Vouldoukis I, Frommel D, Davoust B, Rhodes-Feuillette A, Monjour L.

Vet Parasitol. 1988 Apr;28(1-2):33-41.

PMID:
3291382
29.

In vitro assessment of anti-Leishmania immunity of man acquired with a vaccine.

Vouldoukis I, Ogunkolade BW, Frommel D, Alier N, Monjour L.

Experientia. 1988 Jan 15;44(1):56-7.

PMID:
3350121
30.

Vaccination and treatment trials against murine leishmaniasis with semi-purified Leishmania antigens.

Monjour L, Vouldoukis I, Ogunkolade BW, Hetzel C, Ichen M, Frommel D.

Trans R Soc Trop Med Hyg. 1988;82(3):412-5.

PMID:
3232174
31.

Protective immunity against cutaneous leishmaniasis achieved by partly purified vaccine in a volunteer.

Monjour L, Monjour E, Vouldoukis I, Ogunkolade BW, Frommel D.

Lancet. 1986 Jun 28;1(8496):1490. No abstract available.

PMID:
2873290
32.

Immunoprophylaxis against Leishmania infections with a semi-purified antigen.

Monjour L, Ogunkolade BW, Vouldoukis I, Roseto A, Berneman A, Frommel D.

Trans R Soc Trop Med Hyg. 1986;80(6):1013. No abstract available.

PMID:
3603634

Supplemental Content

Loading ...
Support Center